参考文献/References:
[1] AHSAN H.Diabetic retinopathy--biomolecules and multiple pathophysiology[J].Diabetes Metab Syndr,2015,9(1):51-54.
[2] SCANLON P H,ALDINGTON S J,STRATTON I M.Epidemiological issues in diabetic retinopathy[J].Middle East Afr J Ophthalmol,2013,20(4):293-300.
[3] ROY S,KERN T S,SONG B,STUEBE C.Mechanistic insights into pathological changes in the diabetic retina:Implications for targeting diabetic retinopathy[J].Am J Pathol,2017,187(1):9-19.
[4] CAPITAO M,SOARES R.Angiogenesis and inflammation crosstalk in diabetic retinopathy[J].J Cell Biochem,2016,117(11):2443-2453.
[5] YU Y,CHEN H,SU S B.Neuroinflammatory responses in diabetic retinopathy[J].J Neuroinflammat,2015,12:141.
[6] DOMINICI C,MORENO-BRAVO J A,PUIGGROS S R,RAPPENEAU Q,RAMA N,VIEUGUE P,et al.Floor-plate-derived netrin-1 is dispensable for commissural axon guidance[J].Nature,2017,545(7654):350-354.
[7] VARADARAJAN S G,KONG J H,PHAN K D,KAO T J,PANAITOF S C,CARDIN J,et al.Netrin1 produced by neural progenitors,not floor plate cells,is required for axon guidance in the spinal cord[J].Neuron,2017,94(4):790-799.
[8] ZHANG X,LIU J,XIONG S,XIA X,XU H.Expression of Netrin-1 in diabetic rat retina[J].Eye Sci,2013,28(3):148-152.
[9] 周贤慧,孟旭霞,付浴东,刘鹏辉,胡迭.不同浓度外源性轴突导向因子-1对糖尿病大鼠视网膜血管通透性的影响[J].中华眼底病杂志,2017,33(3):286-289.
ZHOU X H,MENG X X,FU Y D,LIU P H,HU D.The effect of netrin-1 on the retinal vascular permeability in diabetes mellitus rats[J].Chin J Ocul Fundus Dis,2017,33(3):286-289.
[10] 周贤慧,孟旭霞,孙运波,胡迭,郭庆敏.轴突导向因子netrin-1对早期糖尿病大鼠血视网膜屏障的影响[J].中华眼底病杂志,2015,31(5):472-476.
ZHOU X H,MENG X X,SUN Y B,HU D,GUO Q M.The effect of netrin-1 on the retinal vascular permeability in early diabetic retinopathy rats[J].Chin J Ocul Fundus Dis,2015,31(5):472-476.
[11] MILOUDI K,BINET F,WILSON A,CERANI A,OUBAHA M,MENARD C,et al.Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy[J].J Clin Invest,2016,126(8):3006-3022.
[12] ZHANG T,MEI X,OUYANG H,LU B,YU Z,WANG Z,et al.Natural flavonoid galangin alleviates microglia-trigged blood-retinal barrier dysfunction during the development of diabetic retinopathy[J].J Nutr Biochem,2019,65:1-14.
[13] 廖洪霞,魏艳丽,朱晓燕,叶剑,周琦,吕红彬.siRNA沉默FoxO1对STZ诱导的糖尿病大鼠视网膜IL-1β的影响及其作用机制[J].东南大学学报(医学版),2018,37(2):183-190.
LIAO H X,WEI Y L,ZHU X Y,YE J,ZHOU Q,LV H B.The effect of FoxO1 inhibited by siRNA on the expression of IL-1β in diabetic rats retina induced by STZ and its mechanism[J].J Southeast Univ(Med Sci Ed),2018,37(2):183-190.
[14] 晏维,付妤,廖家智,田德安,周珍珍,王伟,等.缺氧环境中Netrin-1对肝癌细胞骨架重组的作用研究[J].中华肝胆外科杂志,2010,16(4):300-304.
YAN W,FU Y,LIAO J Z,TIAN D A,ZHOU Z Z,WANG W,et al.Effect of Netrin-1 on cytoskeletal arrangement induced by hypoxia in HepG2 cells[J].Chin J Hepatob Surg,2010,16(4):300-304.
[15] TAKEUCHI M,SATO T,SAKURAI Y,TAGUCHI M,HARIMOTO K,KARASAWA Y,et al.Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy[J].PLoS One,2017,12(5):e0178230.
[16] LIN C M,TITCHENELL P M,KEIL J M,GARCIA-OCAA A,BOLINGER M T,ABCOUWER SF,et al.Inhibition of atypical protein kinase C reduces inflammation-induced retinal vascular permeability[J].Am J Pathol,2018,188(10):2392-2405.
[17] MIRAKAJ V,THIX C A,LAUCHER S,MIELKE C,MOROTE-GARCIA J C,SCHMIT M A,et al.Netrin-1 dampens pulmonary inflammation during acute lung injury[J].Am J Respir Crit Care Med,2010,181(8):815-824.
[18] ARROBA A I,VALVERDE A M.Modulation of microglia in the retina:new insights into diabetic retinopathy[J].Acta Diabetol,2017,54(6):527-533.
[19] MIRAKAJ V,GATIDOU D,POTZSCH C,KNIG K,ROSENBERGER P.Netrin-1 signaling dampens inflammatory peritonitis[J].J Immunol,2011,186(1):549-555.
[20] STANCO A,SZEKERES C,PATEL N,RAO S,CAMPBELL K,KREIDBERG J A,et al.Netrin-1-alpha3beta1 integrin interactions regulate the migration of interneurons through the cortical marginal zone[J].Proc Natl Acad Sci USA,2009,106(18):7595-7600.
相似文献/References:
[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.